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Abstract
Objective To assess the effect of home based telehealth interventions
on the use of secondary healthcare and mortality.
Design Pragmatic, multisite, cluster randomised trial comparing
telehealth with usual care, using data from routine administrative
datasets. General practice was the unit of randomisation. We allocated
practices using a minimisation algorithm, and did analyses by intention
to treat.
Setting 179 general practices in three areas in England.
Participants 3230 people with diabetes, chronic obstructive pulmonary
disease, or heart failure recruited from practices between May 2008 and
November 2009.
Interventions Telehealth involved remote exchange of data between
patients and healthcare professionals as part of patients’ diagnosis and
management. Usual care reflected the range of services available in the
trial sites, excluding telehealth.
Main outcome measure Proportion of patients admitted to hospital
during 12 month trial period.
Results Patient characteristics were similar at baseline. Compared with
controls, the intervention group had a lower admission proportion within
12 month follow-up (odds ratio 0.82, 95% confidence interval 0.70 to
0.97, P=0.017). Mortality at 12 months was also lower for intervention
patients than for controls (4.6% v 8.3%; odds ratio 0.54, 0.39 to 0.75,
P<0.001). These differences in admissions and mortality remained
significant after adjustment. The mean number of emergency admissions
per head also differed between groups (crude rates, intervention 0.54 v
control 0.68); these changes were significant in unadjusted comparisons
(incidence rate ratio 0.81, 0.65 to 1.00, P=0.046) and after adjusting for
a predictive risk score, but not after adjusting for baseline characteristics.
Length of hospital stay was shorter for intervention patients than for
controls (mean bed days per head 4.87 v 5.68; geometric mean
difference −0.64 days, −1.14 to −0.10, P=0.023, which remained
significant after adjustment). Observed differences in other forms of
hospital use, including notional costs, were not significant in general.
Differences in emergency admissions were greatest at the beginning of
the trial, during which we observed a particularly large increase for the
control group.
Conclusions Telehealth is associated with lower mortality and
emergency admission rates. The reasons for the short term increases
in admissions for the control group are not clear, but the trial recruitment
processes could have had an effect.
Trial registration number International Standard Randomised Controlled
Trial Number Register ISRCTN43002091.
Introduction
Efforts worldwide are dealing with the increasing prevalence
ofchronicdiseaseamonganageingpopulation.Thepastdecade
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Research
RESEARCHhas seen the growing use of telehealth as one possible approach
to this problem. Telehealth involves the remote exchange of
data between a patient and healthcare professionals as part of
thepatient’sdiagnosisandhealthcaremanagement.
1 2Examples
include the monitoring of blood pressure and blood glucose.
Telehealth may help patients to better understand their health
conditions by providing tools for self monitoring, encourage
better self management of health problems, and alert
professional support if devices signal a problem. As a
consequence, telehealth promises better quality and more
appropriate care for each patient, as well as more efficient use
of healthcare resources by reducing the need for expensive
hospital care.
Someresearchsuggeststhattelehealthcanhaveapositiveeffect
on patients with chronic disease, such as improved patient
experiences,clinicalindicators,andqualityoflife,andreduced
use of secondary healthcare (including emergency hospital
admissions).
1 2 Yet, other studies have found either no effect or
anegativeeffect.
3 4Furthermore,suchevidenceisusuallybased
on assimilating findings from a number of small trials, which
could be difficult to generalise,
3 and with many of these trials
not meeting robust evaluation standards.
4 5 A recent review of
self monitoring of blood glucose for people with diabetes
concluded that there was a need for large controlled trials.
6
Investment in telehealth has often been justified partly on the
basis that its cost can be recovered by reductions in the use of
secondary healthcare.
7 However, assessing the scale of such an
effect is complicated. Simple study designs comparing stages
before and after an intervention can produce misleading results
by not having a control group to compare with, particularly if
thepatientsselectedforinterventionhaveahistoryofemergency
care. Such patients have a tendency to show reductions in use
of emergency care over time (that is, regression to the mean).
8
Therefore, in the absence of a control group, whether observed
reductions are the effect of the intervention is unclear.
Analysesofhospitalusearefurthercomplicatedbythefactthat
the distribution of admissions across patients can be highly
skewed. Some high risk patients account for a very high
proportion of admissions.
9 Therefore, small differences in the
risk profile of patients receiving the intervention can greatly
affectobservedoutcomesintermsofhospitaladmission.Several
predictiveriskmodelshavebeendevelopedthatuseinformation
from a person’s health history to predict future hospital use,
10 11
and can offer an opportunity for case mix adjustment. A further
limitation on the size of previous evaluation studies has been
the costs of obtaining information from patients, but it is now
possible to extract information from operational administrative
systemsandusesecuredatalinkageprocedurestotrackresource
use.
In2006,theDepartmentofHealthinEnglandpublishedawhite
paper that included a focus on health and social care for people
with long term needs.
12 The strategy proposed a series of
demonstrator pilots to drive whole systems redesign, supported
byadvancedassistivetechnologies.Thesetechnologiesincluded
telehealth,alongwithasystemofremote,automatic,andpassive
monitoring for patients with social care needs (known as
telecare). The result was the Whole System Demonstrator
project, funded by the Department of Health, which tested the
benefits of integrated care supported by telehealth and telecare
in three sites in England (Cornwall, Kent, and Newham).
One of the project’s aims was to test the effect of telehealth if
delivered at a larger scale than existing pilot schemes, which
wereoftenlimitedtofewerthan100patients.Theresultingtrial
waspragmaticindesign,torecruitandrandomisesuitablylarge
numbers of patients and assess the effect of a broad class of
telehealth and telecare technologies in the context of routine
delivery of care provided by the United Kingdom’s health
service.
7 8 The telehealth part of the study included people
diagnosed with chronic obstructive pulmonary disease, heart
failure, or diabetes. These conditions have high prevalence and
associated healthcare costs. The evaluation covered several
different dimensions.
13 This article is one of five analyses, and
reports on how telehealth affected the use of secondary
healthcare and mortality. The other analyses will assess how
telehealth affected quality of life and cost effectiveness, and
explores the patient, professional, and organisation factors
related to implementation.
Methods
ThetrialprotocolhasbeendescribedbyBowerandcolleagues.
13
Initial discussions with sites indicated that individual
randomisation of patients would probably not be acceptable to
stakeholders. Therefore, we used a pragmatic approach to
randomise general practices. Participants in practices allocated
to the control group were given usual care, which reflected the
rangeofservicesavailableinthetrialsites,excludingtelehealth,
and were offered telehealth or telecare at the end of the trial, if
they were still eligible at that point.
Choices of telehealth devices and monitoring systems varied
among the three trial sites, and there was no attempt to
standardisethesetechnologiesacrosssites.Weincludedabroad
classoftechnologies,andthestudywasnotdesignedorpowered
to examine differences between specific devices or monitoring
systems. Although sites used different protocols for allocating
peripheral devices, they all used a pulse oximeter for chronic
obstructive pulmonary disease, a glucometer for diabetes, and
weighingscalesforheartfailure.Sitesaskedparticipantstotake
clinical readings at the same time each day for up to five days
per week, although the frequency was adjusted according to
theirindividualhistory.Forexample,aparticipantwithdiabetes
and well controlled blood glucose would be asked to take
readings less frequently than another participant with poorly
controlled blood glucose.
In addition to the telemonitoring aspect of the intervention,
symptom questions and educational messages were sent to
participants either via the telehealth base unit or via a set top
box connected to a television. At the end of each session, data
fromclinicalreadingsandsymptomquestionsweretransmitted
to monitoring centres via a secure server. Monitoring centres
were staffed by specialist nurses and community matrons from
localhealthorganisations,whousedprotocolstorespondtothe
information from patients.
All practices in the geographical areas covered by three study
sites (Cornwall, Kent, and Newham in England) were eligible
to participate in the trial. Practices that accepted the invitation
to participate were allocated to an intervention or control group
viaacentrallyadministered,minimisationalgorithmthataimed
to ensure that the groups of practices were similar in terms of
practice size; deprivation index; proportion of non-white
patients;prevalenceofdiabetes,chronicobstructivepulmonary
disease,andheartfailure;andsite.Withineachpractice,patients
aged 18 years or over were deemed eligible on the basis of a
diagnosis in primary or secondary care of chronic obstructive
pulmonarydisease,diabetes,orheartfailure.Wedidnotconfer
eligibility on the basis of formal clinical assessment of disease
severity. Instead, patients were deemed eligible on the basis of
their inclusion on the relevant Quality Outcomes Framework
register in primary care; a confirmed medical diagnosis in
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RESEARCHprimary or secondary care medical records, as indicated by
general practice Read codes or ICD-10 (international
classification of diseases, 10th revision) codes; or confirmation
of disease status by a local clinician (a general practitioner or
communitymatron)orthepatient’shospitalconsultant.Wedid
not exclude patients on the basis of additional physical
comorbidities.
To meet ethical obligations, sites asked patients to complete
and return a data sharing letter if they consented to their data
being shared with the research team. Once this letter had been
returned, patients received a “light touch” visit from members
ofthesiteprojectteam,sometimesincludingclinicalstaff.These
visits aimed to assess the suitability of the patient’s home for
telehealth, provide information regarding the trial, and provide
consent forms for participation. The study design required that
patients were blinded at the point of consent. However, owing
to the large sample size needed for the trial and the extended
period of recruitment, it was not possible to guarantee the
blinding of recruiters to the allocations of general practices
throughout the process.
We assessed the effect of telehealth at the patient level. The
primaryendpointwastheproportionofpeoplewithaninpatient
admissiontohospitalwithinthe12monthtrialperiod.Thestudy
waspoweredonthebasisofdetectingarelativechangeof17.5%
from a baseline of 25% (from a priori site estimates), at 80%
power, and a two sided value of P<0.05. Previous studies in the
older population suggested that the intracluster correlation
coefficient would be about 0.001.
14 We did sample size
calculations using the appropriate formulas,
15 and found that
3000patientswouldneedtoberecruited(25patientsfromeach
of 120 general practices). We examined mortality over 12
months and prespecified secondary endpoints (including the
number of inpatient bed days, emergency admissions, elective
admissions, outpatient attendances, and emergency department
visits, as well as the notional cost of hospital activity to
commissioners of care based on national tariff costs).
Participants were linked at the person level to data for inpatient
andoutpatientsecondaryactivitysourcedfromHospitalEpisode
Statistics, a national data warehouse for England.
16 Participants
werelinkedbytheNHSInformationCentreforhealthandsocial
care, a trusted third party that was the only organisation to have
access to both patient identifiers and data for secondary care
activity. A linked mortality file provided data for all deaths
occurring in and out of hospital. In addition, participants were
linked to local commissioning datasets on visits to emergency
departments,whichincludedallvisitstoemergencydepartment
and not just those that resulted in an admission, and to general
practice datasets. In these data, patient identifiable fields were
removedbeforetransferandNHSnumbersencrypted.Weused
thisencryptedNHSnumbertolinkparticipantstotheemergency
and general practice data.
We restricted analysis of inpatient activity to ordinary
admissions, and excluded transfers, regular ward attendances,
and maternity events (leaving patient classifications 1 and 2
only).Admissionswereclassifiedbydefinedadmissionmethods
into emergency activity (codes 21-28) and elective activity (all
other codes excluding transfers). Bed days included stays after
emergency and elective admissions; same day admissions and
discharges were assigned a stay length of 1 bed day. We
restrictedoutpatientactivitytoappointmentsthatwereattended
(codes 5 and 6).
A separate paper is planned to detail the effect of telehealth on
costs. Here, we included notional costs of hospital care to
summarise overall levels of hospital use in the intervention and
treatment groups across the inpatient and outpatient categories.
We estimated notional costs of care, from Hospital Episode
Statistics data, by applying the set of mandatory and indicative
tariffs used in England for the reimbursement of inpatient and
outpatient care (2008-09 payment by results tariffs).
17 These
tariffs assume a stay of a certain number of days (the “trim
point”),andallowhospitalstochargeaprespecifiedamountfor
each additional excess bed day. Costs were not adjusted for the
regional costs of providing care, and thus were effectively a
weighted activity measure that allowed robust comparison of
the magnitude of care received for control and intervention
participants. We did not include costs for activity not covered
by the tariffs, such as mental health, critical care, cystic fibrosis,
high cost drugs, and outpatient physiotherapy.
The current study was restricted to those patients linked to
administrative data who began the trial before 30 September
2009. The trial start date was taken as the date of telehealth
installationforinterventionpatients,andasthedateofthe“light
touch” visit for control patients. Analysis was based on
comparing activity over 12 months after this date, at the person
level.
Analysis of participants was on the basis of the intended
treatment allocations, and regardless of subsequent withdrawal
from the trial. For randomised trials, formal statistical tests on
the similarity of intervention and control patients have been
thoughttobeinappropriate,sinceallocationsareknowntohave
beenrandom.
18However,inclusterrandomisedtrials,selection
bias is theoretically possible, either through systematic
differences between practices in the control and intervention
groups,orbecauseofsimilardifferencesattheindividuallevel.
19
We presented standardised differences as a summary measure
of differences between groups; we calculated a standardised
difference as the difference between the sample means (or
proportions), divided by the pooled standard deviation.
20
Although various aspects of the trial design mitigated against
theriskofselectionbias,differencesbetweengroupscouldstill
haveoccurredbychance.Weappliedcasemixadjustmentusing
threemodelstoaccountfortheeffectofanydifferencesbetween
groups (box).
In a cluster randomised trial, hospital use for individuals in the
same general practice will tend to be correlated. We accounted
for this degree of clustering by constructing multilevel models
that included random effects at the practice level. Logistic
regressionwasusedfortheadmissionproportionandmortality,
with the exponent of the coefficients used to calculate odds
ratios. For emergency admissions, elective admissions,
outpatient attendances, and emergency department visits, we
used Poisson regression and exponentiated the coefficients to
produce incidence rate ratios. Distribution of healthcare costs
and hospital bed days are typically skewed, with some very
large values and a considerable proportion of the population at
zero. Although opinions differ on how to analyse such data,
21
we incremented and log transformed notional costs and bed
days to meet the assumptions needed for subsequent ordinary
leastsquaresmodelling.Modelcoefficientswereexponentiated
to calculate geometric mean differences. We did all analyses in
Stata 11.
22
The primary analysis assumed a 12 month follow-up for all
patients, regardless of whether they died or not. This tested for
differences between the groups in overall levels of hospital
activity after the introduction of telehealth.However, clinicians
and other healthcare professionals might also be interested in
how telehealth would affect patients’ experiences of admission
to hospital, which would depend on whether they were alive at
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RESEARCHBox: Models used for case mix adjustment
Unadjusted model
The simplest models, although accounting for the effect of clustering, used no additional covariate adjustment.
Adjusted model
A more complex model additionally controlled for residual imbalances in a set of characteristics predictive of future hospital use. These
characteristics included age, sex, ethnicity, site, number of chronic health conditions, principal long term condition (diabetes, chronic
obstructive pulmonary disease, or heart failure), an area based deprivation score (national quartiles of the index of multiple deprivation
2007), and a metric corresponding to the endpoint calculated over several periods within the two years before recruitment. The number of
chronic health conditions was a count of diagnoses recorded on inpatient data over the three years before starting the trial. We assigned
principal long term conditions using a pragmatic approach according to published criteria.
13
Combined model
More complex case mix adjustment was conducted using the combined model.
11 This model is a standard instrument designed to estimate
the probability that an individual would be admitted to an emergency hospital department within a 12 month period. The combined model
score accounts for 72 variables related to age, sex, recorded health conditions, previous hospital use, and prescriptions. These variables
are sourced using administrative data from general practices as well as from local hospital commissioning datasets.
The combined model was originally derived using data for 2002-05;
11 we revalidated its performance on more recent data covering the period
from April 2007 to March 2009. Revalidation used data extracted for the trial sites excluding trial participants. For the case mix adjustment,
we calculated the combined model score for each participant at the end of the month before the start date. If a general practice did not grant
approval for us to extract data, we imputed scores for patients on the basis of the available information, which included age, sex, and hospital
data. We used single imputation on the basis of linear regression on the logit scale.
that point. Such effects may be different if telehealth affected
the mortality rate. Therefore, we did secondary analyses to
assessgroupdifferencesinadmissionratesatanypointintime,
on the condition that participants were alive just before that
point in time and had not already been admitted. This analysis
treated death as a form of statistical censoring and used the
Kaplan-Meier curve.
23 Although the Kaplan-Meier curve did
not take into account differences between intervention and
controlgroupsatbaseline,wealsoestimatedthecorresponding
adjusted hazard ratio. We calculated hazard ratios using a Cox
proportional hazards model,
24 which included covariate
adjustment according to the set of baseline variables (box) and
random frailties to allow for homogeneity within practices.
25
Results
Data extraction, linkage, and processing
We allocated 238 practices to control or intervention groups.
Although 59 practices eventually did not supply participants
for the trial, sites assessed 15 171 patients for eligibility and
sent data sharing consent forms; 5279 (34.8%) of these patients
agreed to a “light touch” visit. Some patients did not consent
to take part in the trial after this visit. Sites recruited 1625
controlpatientsand1605interventionpatientsfrom179general
practices (fig 1⇓), with each practice recruiting an average of
18 patients. Recruitment started in May 2008 and was planned
to finish in September 2009; we excluded seven patients who
were recruited after this finish date. In addition, 69 patients
could not be linked to administrative data on secondary care
use. Overall, we included 1584 control patients and 1570
intervention patients in the analyses (98% of those recruited).
Wecalculatedfullcombinedmodelscoresfor1397controland
1365 intervention patients (88% of those included in the
analyses), and imputed scores for the remainder of patients.
Most inpatient and outpatient hospital activity for the selected
patients could be assigned unit costs using our methods. We
assigned unit costs to 3189 (96.3%) of 3310 inpatient spells
experienced by participants during the 12 months before the
start of the trial, and to 13 670 (86.7%) of 15 766 outpatient
attendances.
Baseline characteristics and trends in hospital
activity
Tables 1⇓ and 2⇓ show that intervention and control patients
were similar at baseline (all but one standardised difference
<10%).Thelargestdifferencebetweeninterventionandcontrol
patients related to diabetes as an index condition (25.9% v
21.6%), followed by mean age (69.7 v 70.9 years). Intervention
patients also had less costly hospital activity than controls in
the 90 days before the start of the trial (£427 (€529; $662) v
£506).
Figure 2⇓ shows trends in hospital activity without adjusting
for clustering or baseline covariates (that is, as crude data). The
break in the chart corresponds to the trial start date, and the
chart summarises activity over a series of quarters before and
after this date. Rates of emergency hospital admission had
peaked for both intervention and control groups at around six
quarters before the start of the trial. After the trial began,
emergency admissions increased for the control group, from
0.13perheadinthequarterimmediatelybeforeto0.18perhead
in the quarter immediately after. Emergency department visits
also increased over this period, and the rate of conversion of
emergencydepartmentvisitsintoadmissionsroseslightlyfrom
53% to 58%. After the initial increase in activity for the control
group, rates of emergency admission for the two groups began
to converge, although a difference in favour of the intervention
group seemed to persist for the entire follow-up period. Table
3⇓showssummaryfiguresforthecruderatesofhospitalactivity
during the follow-up period.
Analysis of primary and secondary endpoints
Oftheinterventionparticipants,42.9%wereadmittedtohospital
during the 12 months of the trial, compared with 48.2% of
controls (table 3). These proportions corresponded to an
unadjusted odds ratio of 0.82 (95% confidence interval 0.70 to
0.97, P=0.017; table 4⇓). The odds ratio takes into account
clustering at the general practice level. The intracluster
correlation coefficient (0.017) was higher than assumed in the
original power calculations.
The odds ratio for the admission proportion at 12 months
remainedsignificantafterweadjustedforbaselinecharacteristics
and also after we adjusted for the combined model score. We
assessed the performance of the combined model as a
discriminatory tool to predict emergency hospital admissions
by using data from the trial sites (excluding trial participants).
We estimated the area under the receiver operating
characteristics curve to be 0.746 (n=1 523 038).
Duringthetrial,fewerparticipantsdiedintheinterventiongroup
than in the control group (4.6% v 8.3%; unadjusted odds ratio
0.54, 95% confidence interval 0.39 to 0.75, P<0.001).
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RESEARCHDifferences remained significant after adjustment for the
combined model score, although we could not adjust for the set
of baseline characteristics because models did not converge.
Ofthesecondaryendpoints,emergencyadmissions,emergency
department visits, bed days, and mortality showed significant
findings in some or all of the models. Intervention participants
underwent0.54emergencyadmissionsperhead,comparedwith
0.68 for controls (crude rates), corresponding to an unadjusted
incidence rate ratio of 0.81 (95% confidence interval 0.65 to
1.00, P=0.046). However, after we adjusted for baseline
characteristics, the upper end of the confidence interval for
emergency admissions reached 1.
On average, intervention participants attended emergency
departments0.64timesperheadduringthetrial,comparedwith
0.75forcontrols.Thisdifferencewassignificantintheadjusted
estimatesonly(incidencerateratio0.85,0.73to1.00,P=0.044).
The intervention and control groups spent an average of 4.87
and 5.68 days in hospital, respectively (unadjusted geometric
mean difference −0.64 days, −1.14 to −0.10, P=0.023); this
difference remained significant after adjustment.
Notional costs of hospital activity to commissioners of care
were £188 per head lower for intervention participants than for
controls (crude rates). Confidence intervals for the geometric
mean were very wide and differences were not significant in
any of the models (adjusted geometric mean difference −£242,
95% confidence interval −629 to 228, P=0.290).
Secondary analysis of the Kaplan-Meier curves and Cox
regression (fig 3⇓) confirmed that differences in the admission
proportion remained significant after censoring observations at
death (hazard ratio 0.87, 95% confidence interval 0.78 to 0.98,
implyingfeweradmissionsforthetelehealththancontrolgroup).
Graphical methods indicated that the underlying proportional
hazardsassumptionwasreasonable.WhereSchoenfeldresidual
tests were significant,
26 results remained robust to alternative
model specification.
Discussion
Principal findings of the study
Among a set of patients with chronic obstructive pulmonary
disease, diabetes, or heart failure, this study has shown that a
smaller proportion of telehealth users than controls were
admitted to hospital during a 12 month follow-up. This effect
remained significant after adjusting for baseline characteristics
and for a predictive risk score. However, the magnitude of the
group difference in admission proportion was relatively small
(10.8%, 95% confidence interval 3.7% to 18.1%), and smaller
than the size that the planned study design was able to detect
(17.5%), raising questions about the clinical relevance of the
results. The significance of some of the effects reflected the
increasedpowerofthestudy,owingtothehigherthanassumed
baseline level of admissions and to the larger number of small
practices (even though the intracluster correlation coefficient
was higher than assumed).
Intervention patients were significantly less likely to die within
12 months than controls. We also observed small differences
inthemeannumberofemergencyadmissionsperheadbetween
the intervention and control groups (crude rate 0.54 v 0.68;
difference 0.14). These changes were significant in the
unadjusted comparisons and when we adjusted for a predictive
riskscore,butnotwhenweadjustedforbaselinecharacteristics.
Hospital bed days were significantly lower among intervention
patients than controls, which reflected the reduced admission
proportion overall.
For the other measures of hospital use (including the number
of elective admissions, outpatient attendances, and emergency
department visits), group differences were not significant in
general. Crude differences in notional hospital costs to
commissioners of care were also not significant and were
relatively small (£188 per head over 12 months), especially
compared with the potentially high costs of these types of
telehealth intervention
27-29, which we did not take into account.
In view of our results showing confidence intervals crossing
the line of no difference, we cannot conclude that telehealth
reduces secondary care costs over 12 months. A formal cost
effectiveness analysis of the Whole System Demonstrator
intervention has been undertaken on a subset of participants,
using self reported data for hospital use and other services and
taking into account the intervention cost, compared with health
related quality of life and other outcomes.
Differencesinhospitalusewereattheirmostmarkedatthestart
of the trial, when we observed a distinct increase in admissions
forthecontrolgroup.Ifweexcludedactivityfromthefirstthree
months of the trial, differences in the admission proportion
would not have been significant under any of the models.
Therefore, this increase has implications for the interpretation.
Trial recruitment processes may have led indirectly to changes
in service use for control patients; however, the same processes
might also have affected intervention patients in the absence of
telehealth. In this case, differences in admissions can be
attributedtotelehealth,butwiththelimitationthatthetrialcould
have affected the context for the delivery of care for both trial
groups.
One explanation for the increase in emergency admissions
observed for the control group is that professionals may have
identified additional health problems and unmet needs during
the recruitment process and could have decided to intervene
with control patients not allocated to receive telehealth. This
explanation assumes that, if professionals found additional
relevant health problems among the intervention group, they
were content to manage these in a community setting, with the
support of the remote monitoring.
The trial recruitment process might have also raised patients’
awareness of their health conditions. Anxiety could have
increased as a result of being allocated to the control group, to
the extent that these patients were more likely to present at
emergency departments and be admitted than intervention
patients. The decision to offer telehealth to control patients at
the end of the 12 month period, while designed to reduce
attrition rates, could have increased anxiety if it encouraged a
stronger sense that they were being denied access to support
that could be beneficial. A final possible explanation for the
increase is that biases could have resulted during patient
selection, in which only 35% of patients agreed to the initial
“lighttouch”visit.Therecouldhavebeenapropensitytoselect
controls with a higher risk of short term admission and
intervention patients with a lower risk. However, observed
differences were limited between intervention and control
groups, and case mix adjustment was applied.
Strengths and weaknesses of the study
This particular analysis is one of a series planned by the Whole
System Demonstrator Evaluation Team, and was limited to
comparisonsofinpatient,outpatient,andemergencydepartment
hospital use and mortality. We did not consider the full range
of health and social care services, and intervention and control
groups could have had differences in the use of primary care,
community services, or social care. Telehealth could also have
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RESEARCHhad different effects according to long term condition or other
patientcharacteristics.Althoughweassignedunitcoststomore
than 95% of inpatient activity, we did not consider costs for
some elements of hospital care, including mental health and
criticalcare,whichhadnonationaltariff.Useofnationaltariffs
meant that the analysis was relevant to decisions made by
commissioners of care, who align with hospital reimbursement
guidance, but the economic costs of providing care will differ
from the notional costs shown here, and there are regional
differences in the costs of providing care.
Although service use could have resource implications, it does
not necessarily correlate with health status. Assessment of the
effect of interventions should be multidimensional,
30 and
important differences could also exist in health outcomes, cost
effectiveness, and patient perceptions. These outcomes are
explored in the related theme analyses. Telehealth could also
have had knock-on effects in non-study patient groups, by
freeing up clinical time and resources to care for non-study
patients, or by diverting the attention of community teams
towards those patients on the trial.
Thestudyusedadministrativedatasets.Asaresult,personlevel
data were available for 98% of participants. Although these
datasets avoided problems of non-response, the quality of data
wasnotdirectlyundertheresearchteam’scontrol.Patientstend
to underestimate resource use compared with healthcare
providers,
31 but several studies have pointed out potential
problemswithusingadministrativedata,suchaslimitedinsight
into the quality and appropriateness of care.
32 33
Selectionbiasisrecognisedasariskinclusterrandomisedtrials,
inwhichsystematicdifferencescanoccurbetweenintervention
and control groups at both the cluster and individual level.
19 At
the individual level, if the trial recruiters had foreknowledge of
theallocationgroup(aswasoftenthecasehere),biascanresult
throughtherecruitmentofdifferenttypesofparticipantintothe
two groups. We designed this trial to minimise the possibility
of bias within the context of a complex community based
intervention. An independent team randomised allocations of
practices and a minimisation algorithm aimed to ensure that
intervention and control practices were similar in terms of
practice size, disease prevalence, and other characteristics. At
the individual level, we found no large differences in the
characteristics of control and intervention participants at
baseline. However, we saw group differences in the median
number of participants per general practice (8.5 for telehealth
v 12 for controls). Case mix adjustment controlled for observed
differences between intervention and control groups.
We based this analysis on an intention to treat method, which
compares patients according to their assigned intervention or
control group. Although some patients did not receive their
allocatedinterventions,thesenumbersweresmall.Asubstantial
proportion of the intervention group could have stopped using
telehealth before the end of the 12 months. This study had
conservativeestimatesbecause,inothertelehealthapplications,
equipment might be removed from patients who stop using it.
34
The trial design aimed to minimise differential rates of attrition
between intervention and control groups, by ensuring that all
practiceswereallocatedtoreceiveatelemonitoringintervention
(telehealthortelecare),andthatcontrolparticipantswereoffered
a telemonitoring intervention at the end of the trial period, if
they were still eligible.
Theeffectoftelehealthshouldbeconsideredasjustoneelement
within the health system in which it was used. All participating
practices and patients in the study could have benefited from
thewiderserviceredesignassociatedwiththesetrials,including
those assigned to usual care. Therefore, the study assessed the
addedvalueoftelehealthoverandabovetheeffectsofthiswider
service redesign.
The study aimed to review a broad class of telehealth devices
and not to compare specific devices and monitoring systems.
Our results reflect specific models of the introduction of
telehealth, based on a series of decisions by local teams. There
were differences in the interventions offered by the three sites.
Although this plurality might be seen as problematic for the
purposes of replicating and linking specific aspects of the
interventions to likely changes in hospital use, in some ways it
is the merit of a pragmatic trial. Other sites introducing
telehealth will make choices driven by local contexts in the
same way as did the sites in the present study, so the ability to
reflectreallifeapplicationsoftelehealthwilladdgeneralisability
to the study findings. However, the sites were specifically
chosen for their innovations in these areas of care, and
conclusions about the effectiveness of telehealth might depend
on the environment in which it is used.
Strengths and weaknesses in relation to other
studies
Assessment of the effectiveness of telehealth is usually based
on assimilating evidence from several small trials, which could
make findings difficult to generalise. By contrast, with over
3100 participants, this study is one of the largest randomised
trials of telehealth done so far. The focus on combining three
disease groups is novel and allowed us to examine the overall
effect of telehealth across populations with chronic disease.
However, telehealth could have varying effects in different
groups.Otherstudieshavetypicallyexaminedconditiongroups
separately; thus, comparisons between studies are not
straightforward.
Paré and colleagues reviewed 65 empirical studies across four
conditions and distinguished the effects of telehealth between
different conditions. They suggested that effects on a range of
measures (for example, reduced visits to emergency
departments,hospitaladmissions,andaveragelengthofhospital
stay) were more consistent in pulmonary and cardiac disorders
than in diabetes and hypertension.
35
A systematic review of studies for heart failure reported that
telemonitoring reduced all cause mortality, whereas both
telemonitoring and structured telephone support reduced
admissionsforheartfailure.
36However,findingswerebasedon
generalising a large number of studies with a mean sample size
of 330. A study showed that a telehealth intervention that
included portable devices significantly reduced costs and
admissions for people with heart failure. This was based on a
samplesizeof460,althoughthestudywasadequatelypowered
for the larger effect size it assumed.
29 A more recent study of
1653 patients with heart failure found no significant effect on
hospital use or mortality.
37 In relation to the management of
chronic obstructive pulmonary disease, several studies showed
lowerratesofemergencyadmissionsforpatientsreceivinghome
monitoring plus telephone support,
38-40 although one review
noted that mortality rates were greater in patients receiving
telephonesupportthanthosereceivingusualcare.
39Evaluations
oftelehealthinterventionsforpeoplewithdiabeteshavefocused
on the achievement of a clinical outcome in terms of glycaemic
control,
41 42 with some reported success.
There is also a question about the effect of interventions that
combinetelemonitoringwitheducationalandmotivationaltools,
suchasthosewestudied,comparedwithinterventionsconsisting
of telemonitoring only. Our study was not designed to answer
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RESEARCHthis question. In a study by Domingo and colleagues of patients
with heart failure receiving multidisciplinary care, those who
used motivational support tools combined with telemonitoring
of weight, blood pressure, and heart rate, thought that their
qualityoflifehadimproved.Thesepatientsalsospentlesstime
in hospital after the intervention than before, although before
and after comparisons can be vulnerable to regression to the
mean. Researchers randomised patients to groups with and
without the telemonitoring element and found no significant
group differences.
43
Possible explanations and implications for
clinicians and policymakers and other
researchers
Our results suggest that telehealth helped patients to avoid the
need for emergency hospital care. The mechanism for this is
not yet clear. Telehealth could help patients manage their
conditions better and therefore reduce the incidence of acute
exacerbationsthatneedemergencyadmissions.Telehealthcould
also change people’s perception of when they need to seek
additional support, as well as professionals’ decisions about
whethertoreferoradmitpatients.Furtheranalyseswillprovide
insights into the mechanisms by which telehealth can lead to
reductions in admission rates.
13
The reduced mortality observed in the intervention group will
be an important motivator to invest in these interventions and
similar technologies. Although the observed difference in
emergencyadmissionsassociatedwiththeinterventionindicates
some potential to reduce use of secondary care, the findings
need to be tempered by the estimated scale of the difference in
notional hospital cost savings for commissioners of care and
the cost of the intervention. Furthermore, the increases seen in
emergency admissions among control participants suggest that
the trial recruitment processes had an impact. The effect on
quality of life must also be considered as part of a broader cost
effectivenessanalysis.Forcommissionersofcareservices,there
are questions about whether any reduction in hospital use for
patients receiving telehealth translates to an overall change at
theorganisationallevel.Anybeddaysreleasedasaresultcould
be filled with non-study patients rather than released as cash
savings. In turn, this could have meant that health benefits
accruedtonon-studypatients,whichwerenottakenintoaccount
here.
The observation of a group effect between intervention and
controls could mask differences by subgroups. For local
practitioners, it is important to assess whether benefits of
telehealth are greater in particular patient types, to inform
decisions about prioritising the intervention in specific patient
groups. For example, Maclean and colleagues observed that
telehealth interventions probably did not result in clinically
relevant improvements in health outcomes in patients with
relatively mild asthma,
44 but could have a role in patients with
more severe disease who are at high risk of admission. The
current study was not designed to answer these specific
questions.
The effect of telehealth could be intricately linked to wider
issues about how health systems operate. It is unclear whether
effects are attributable to the technology itself or attributable to
how it is implemented,
34 and telehealth could be disruptive
becauseitrequiressomeprofessionalgroupstoworkindifferent
ways.
This analysis is one part of the complete evaluation, and the
Whole System Demonstrator trial in its entirety will allow a
wider discussion of issues around the effects on cost
effectiveness, quality of life, and patients’ and carers’
experiences as well as changes at the organisational level.
We thank all the study participants; staff from the three sites; Bupa
Health Dialog for managing the remote collection of primary care data
and providing predictive modelling analytic data files; and Theo
Georghiou and Ian Blunt for assistance with classifying statistics data
for hospital episodes and applying unit costs.
Contributors: AS led the collection of administrative datasets, analysis,
and manuscript drafting. MB, JD, and JB took part in the original design
of this element of the work and contributed to the analysis. Additionally,
HD, SH, MK, AR, RF, JH, and SN were involved in the development of
the study protocol for the overall project. SN was principal investigator
of the Whole System Demonstrator trial and HD was statistical adviser
and guarantor of the statistical robustness of the overall project. MC,
SH, and LR co-ordinated the daily implementation of the trial protocol
and maintained trial participants’ data. CH provided input to the analysis.
All authors reviewed the manuscript. The Whole System Demonstrator
Evaluation Team contributed to periodic discussions of the data collected
for this study during team meetings, and commented on interim
documents produced during the study.
Funding: The study was funded by the Department of Health in England.
The Department of Health reviewed the protocol for the study and
provided project manager support for the implementation of telehealth.
The University College London Hospitals and University College London
were the Whole System Demonstrator study sponsors. Their role as
sponsors was to ensure that the study was conducted in accordance
with the Research Governance Framework for Health and Social Care
(2nd ed, April 2005) and to confirm that arrangements were in place for
the initiation, management, monitoring, and financing of the trial.
Competing interests: All authors have completed the Unified Competing
Interest form at www.icmje.org/coi_disclosure.pdf (available on request
from the corresponding author) and declare: support from the
Department of Health and the University College London Hospitals and
University College London; several authors have undertaken evaluative
work funded by government or public agencies but these have not
created competing interests; no other relationships or activities that
could appear to have influenced the submitted work.
Ethical approval: The study was approved by Liverpool research ethics
committee (reference 08/H1005/4).
Data sharing: no additional data available.
1 McLean S, Protti D, Sheikh A. Telehealth for long term conditions. BMJ 2011;342:d120.
2 Sood S, Mbarika V, Jugoo S, Dookhy R, Doarn CR, Prakash N, et al. What is telemedicine?
A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed
J E Health 2007;13:573-90.
3 Chaudhry SI, Mattera JA, Krumholz HM. Telemonitoring in patients with heart failure.
Authors’ response to letters. N Engl J Med 2011;364;1078-80.
4 Barlow J, Singh D, Bayer S, Curry R. A systematic review of the benefits of home telecare
for frail elderly people and those with long-term conditions. J Telemed Telecare
2007;13:172-9.
5 Bergmo TS. Can economic evaluation in telemedicine be trusted? A systematic review
of the literature. Cost Eff Resour Alloc 2009;7:18.
6 Farmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine
interventions to support blood glucose self-monitoring in diabetes. Diabet Med
2005;22:1372-8.
7 Cruickshank J, Beer G, Winpenny E, Manning J. Healthcare without walls: a framework
for delivering telehealth at scale. 2020 health. 2010. www.2020health.org/2020health/
Publication/NHSit/telehealth.html.
8 Roland M, Dusheiko M, Gravelle H, Parker S. Follow up of people aged 65 and over with
a history of emergency admissions: analysis of routine admission data. BMJ 2005;330:289.
9 Billings J, Dixon J, Mijanovich T, Wennberg D. Case finding for patients at risk of
readmission to hospital: development of algorithm to identify high risk patients. BMJ
2006;333:327.
10 Nuffield Trust. Predictive risk and health care: an overview. Nuffield Trust, 2011.
11 Wennberg D, Siegel M, Darin B, Filipova N, Russell R, Kenney L, et al. Combined
predictive model: final report and technical documentation. 2006.
12 Department of Health. Our health, our care, our say: a new direction for community
services. Cm 6737. The Stationery Office, 2006.
13 Bower P, Cartwright M, Hirani SP, Barlow J, Hendy J, Knapp M, et al. A comprehensive
evaluation of the impact of telemonitoring in patients with long-term conditions and social
care needs: protocol for the Whole System Demonstrator cluster randomised trial. BMC
Health Serv Res 2011;11:184.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e3874 doi: 10.1136/bmj.e3874 (Published 21 June 2012) Page 7 of 15
RESEARCHWhat is already known on this topic
The known effect of telehealth on secondary healthcare use for patients with chronic diseases has been based on assimilating findings
from several small trials, often with conflicting results
What this study adds
Among people with chronic obstructive pulmonary disease, heart failure, or diabetes, a broad class of telehealth technologies could be
associated with reduced rates of mortality and emergency hospital admission
This effect, however, could be linked to short term increases in hospital use observed in the control group that may have been affected
by recruitment processes during the trial
The estimated scale of hospital cost savings for commissioners of care is modest, and the cost of the telehealth intervention should also
be taken into account
14 Lancaster GA, Chellaswamy H, Taylor S, Lyon D, Dowrick C. Design of a clustered
observational study to predict emergency admissions in the elderly: statistical reasoning
in clinical practice. J Eval Clin Pract 2007;13:169-78.
15 Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomised trials. Int J
Epidemiol 1999;28:319-26.
16 Hospital Episode Statistics. HESonline. 2012. www.hesonline.nhs.uk.
17 Department of Health. Payment by results: guidance and tariff for 2008-09. Department
of Health, 2007.
18 Roberts C, Torgerson DJ. Baseline imbalance in randomised controlled trials. BMJ
1999;319:185.
19 Puffer S, Torgerson DJ, Watson J. Evidence for risk of bias in cluster randomised trials:
review of recent trials published in three general medical journals. BMJ 2003;327:785.
20 Flury BK, Reidwyl H. Standard distance in univariate and multivariate analysis. Am Stat
1986;40:249-51.
21 Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be
analysed? BMJ 2000;320:1197-200.
22 StataCorp. Stata Statistical software: release 11. StataCorp LP, 2009.
23 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat
Assoc 1958;53:457-81.
24 Cox DR, Oakes D. Analysis of survival data. Chapman and Hall, 1984.
25 Glidden DV, Vittinghoff E. Modelling clustered survival data from multicentre clinical trials.
Stat Med 2004;23:369-88.
26 Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika
1982;69:239-41.
27 Barlow J, Bayer S, Curry R, Hendy J. The costs of telecare: from pilots to mainstream
implementation. In: Curtis L, ed. Unit costs of health and social care 2007. Personal Social
Services Research Unit, 2007.
28 Mason JM, Young RJ, New JP, Gibson JM, Long AF, Gambling T, et al. Economic analysis
of a telemedicine intervention to improve glycemic control in patients with diabetes mellitus:
illustration of a novel analytic method. Dis Manage Health Outcomes 2006;14:377-85.
29 Giordano A, Scalvini S, Zanelli E, Corrà U, Longobardi GL, Ricci VA, et al. Multicenter
randomised trial on home-based telemanagement to prevent hospital readmission of
patients with chronic heart failure. Int J Cardiol 2009;131:192-9.
30 Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures
in health care. I: applications and issues in assessment. BMJ 1992;305:1074-7.
31 Richards SH, Coast J, Peters TJ. Patient-reported use of health services resources
compared with information from health providers. Health Soc Care Community
2006;11:510-8.
32 Lezzoni LI. Assessing quality using administrative data. Ann Intern Med 1997;127:666-74.
33 Roos LL, Mustard CA, Nicol JP, McLerran DF, Malenka DJ, Young TK, et al. Registries
and administrative data: organization and accuracy. Med Care 1993;31:201-12.
34 Everett W, Kvedar JC, Nesbitt TC. Telemonitoring in patients with heart failure. N Engl J
Med 2011;364:1079.
35 Paré G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic
diseases: the evidence base. J Am Med Inform Assoc 2007;14:269-77.
36 Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, et al. Structured
telephone support or telemonitoring programmes for patients with chronic heart failure.
Cochrane Database Syst Rev 2010;8:CD007228.
37 Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, et al. Telemonitoring in
patients with heart failure. N Engl J Med 2010;363:2301-9.
38 Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupré A, Begin R, et al. Reduction of
hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific
self-management intervention. Arch Intern Med 2003;163:585-91.
39 Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, et al. Home telehealth for
chronic obstructive pulmonary disease a systematic review and meta-analysis. J Telemed
Telecare 2010;16:120-7.
40 Farrero E, Escarrabill J, Prats E, Maderal M, Manresa F. Impact of a hospital-based
home-care program on the management of COPD patients receiving long-term oxygen
therapy. Chest 2001;119;364-9.
41 Trief PM, Teresi JA, Eimicke JP, Shea S, Weinstock RS. Improvement in diabetes self-
efficacy and glycaemic control using telemedicine in a sample of older, ethnically diverse
individuals who have diabetes: the IDEATel project. Age Ageing 2009;38:219-25.
42 Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WAB, et al.
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not
using insulin. Cochrane Database Syst Rev 2005,3:CD005060.
43 Domingo M, Lupón J, González B, Crespo E, López R, Ramos A, et al. Noninvasive
remote telemonitoring for ambulatory patients with heart failure: effect on number of
hospitalizations, days in hospital, and quality of life. CARME (CAtalan Remote Management
Evaluation) Study. Rev Esp Cardiol 2011;64:277-85.
44 McLean S, Chandler D, Nurmatov U, Liu J, Pagliari C, Car J, et al. Telehealthcare for
asthma. Cochrane Database Syst Rev 2010;10:CD007717.
Cite this as: BMJ 2012;344:e3874
This is an open-access article distributed under the terms of the Creative Commons
Attribution Non-commercial License, which permits use, distribution, and reproduction in
any medium, provided the original work is properly cited, the use is non commercial and
is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-
nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e3874 doi: 10.1136/bmj.e3874 (Published 21 June 2012) Page 8 of 15
RESEARCHTables
Table 1| Baseline characteristics of study patients. Data are no (%) of patients unless stated otherwise
Standardised difference (%) Intervention group (n=1570) Control group (n=1584)
— 92 85 No of practices
— 8 (1-77) 12 (1-98) No of patients per practice (median (range))
Index long term condition
−5.1 739 (47.1) 786 (49.6) Chronic obstructive pulmonary disease
10.0 406 (25.9) 342 (21.6) Diabetes
−3.8 425 (27.1) 456 (28.8) Heart failure
−3.0 1.8 (1.8) 1.8 (1.8) No of chronic health conditions per patient
(mean (SD))
Site
−6.7 558 (35.5) 614 (38.8) Cornwall
−1.0 563 (35.9) 576 (36.4) Kent
8.4 449 (28.6) 394 (24.9) Newham
Age
−9.7 69.7 (11.6) 70.9 (11.7) Mean (SD) age in years
2.9 463 (29.5) 446 (28.2) <65 years
7.1 548 (34.9) 500 (31.6) 65-74 years
−6.9 446 (28.4) 500 (31.6) 75-84 years
−5.6 113 (7.2) 138 (8.7) ≥85 years
1.3 647 (41.2) 643 (40.6) Female
Ethnicity
−4.4 1127 (71.8) 1168 (73.7) White
2.1 182 (11.6) 173 (10.9) Non-white
3.5 261 (16.6) 243 (15.3) Unknown
Area level deprivation*
2.9 28.4 (14.8) 27.9 (13.5) Mean (SD)
8.0 137 (8.8) 105 (6.6) First quartile
−1.8 258 (16.5) 272 (17.2) Second quartile
−5.6 522 (33.4) 571 (36.1) Third quartile
2.5 644 (41.3) 633 (40.0) Fourth quartile
Combined model score†
−0.3 0.260 (0.202) 0.261 (0.200) Mean (SD)
0.0 221 (16.2) 226 (16.2) Low risk category
3.0 440 (32.2) 431 (30.9) Moderate risk category
−2.7 559 (41.0) 591 (42.3) High risk category
−0.1 145 (10.6) 149 (10.7) Very high risk category
SD=standard deviation.
*N=1581 for control group, n=1561 for intervention group. First quartile is least deprived, fourth quartile is most deprived.
†N=1397 for control group, n=1365 for intervention group. Risk categories denote top proportions of site population: very high risk (0.5%), high risk (0.5-5%),
moderate risk (5-20%), and low risk (20-100%).
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RESEARCHTable 2| Baseline characteristics of study patients, in relation to previous hospital use before start of trial. Data are mean (standard deviation)
unless stated otherwise
Standardised difference (%) Intervention group (n=1570) Control group (n=1584) Characteristic and period before start of trial
Admission proportion (%)
−3.2 16.3 (n=256) 17.5 (n=277) 1-90 days
0.1 39.3 (n=617) 39.3 (n=622) 91-365 days
−4.9 47.1 (n=740) 49.6 (n=785) 366-730 days
Emergency admissions per head
−3.3 0.11 (0.44) 0.13 (0.45) 1-90 days
−3.8 0.42 (0.94) 0.45 (1.01) 91-365 days
−5.5 0.54 (1.07) 0.60 (1.19) 366-730 days
Bed days per head
−2.3 0.84 (3.81) 0.94 (4.69) 1-90 days
−5.3 3.00 (8.96) 3.54 (11.25) 91-365 days
−0.6 4.57 (12.77) 4.65 (11.45) 366-730 days
Elective admissions per head
0.5 0.11 (0.48) 0.11 (0.40) 1-90 days
0.6 0.36 (1.10) 0.36 (0.95) 91-365 days
−2.3 0.49 (1.30) 0.52 (1.29) 366-730 days
Outpatient attendances per head
−4.7 1.14 (1.97) 1.23 (1.97) 1-90 days
−2.4 3.75 (4.98) 3.87 (5.24) 91-365 days
−1.9 4.63 (6.12) 4.75 (6.35) 366-730 days
Emergency department visits per head
1.1 0.14 (0.48) 0.13 (0.44) 1-90 days
0.9 0.42 (1.10) 0.41 (1.05) 91-365 days
−1.1 0.46 (1.21) 0.47 (1.05) 366-730 days
Tariff cost per head (£ per head)
−6.3 427 (1177) 506 (1311) 1-90 days
−5.1 1706 (3116) 1879 (3712) 91-365 days
−2.7 2296 (4143) 2411 (4342) 366-730 days
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RESEARCHTable 3| Hospital use and mortality during trial (unadjusted for clustering and covariates). Data are mean (standard deviation) unless stated
otherwise
Percentage difference (95% CI) Absolute difference (95% CI) Intervention group (n=1570) Control group (n=1584)
−10.8% (−18.1% to −3.7%) −5.2 (−8.7 to −1.8) 42.9 (n=674) 48.2 (n=763) Admission proportion (%)
−44.5% (−65.3% to −23.8%) −3.7 (−5.4 to −2.0) 4.6 (n=72) 8.3 (n=131) Mortality (%)
−20.6% (−33.8% to −7.4%) −0.14 (−0.23 to −0.05) 0.54 (1.16) 0.68 (1.41) Emergency admissions per head
−14.3% (−30.6% to 2.0%) −0.07 (−0.15 to 0.01) 0.42 (0.99) 0.49 (1.31) Elective admissions per head
1.7% (−8.3% to 11.8%) 0.08 (−0.39 to 0.55) 4.76 (6.74) 4.68 (6.81) Outpatient attendances per head
−14.7% (−28.0% to −1.3%) −0.11 (−0.21 to −0.01) 0.64 (1.26) 0.75 (1.58) Emergency department visits per
head
−14.3% (−32.4% to 3.9%) −0.81 (−1.84 to 0.22) 4.87 (14.35) 5.68 (15.10) Bed days per head
−7.7% (−19.4% to 4.0%) 188 (−474.9 to 98.8) 2260 (4117) 2448 (4099) Tariff costs per head (£)
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RESEARCHTable 4| Results of mixed models (including case mix adjustment)
P Estimate (95% CI) Model Endpoint (interpretation)
0.017 0.82 (0.70 to 0.97) Unadjusted Admission proportion (odds ratio)
0.026 0.82 (0.69 to 0.98) Adjusted
0.016 0.82 (0.69 to 0.96) Combined model
<0.001 0.54 (0.39 to 0.75) Unadjusted Mortality (odds ratio)*
<0.001 0.53 (0.39 to 0.72) Combined model
0.046 0.81 (0.65 to 1.00) Unadjusted Emergency admissions (incidence rate ratio)
0.056 0.85 (0.72 to 1.00) Adjusted
0.011 0.81 (0.69 to 0.95) Combined model
0.219 0.89 (0.75 to 1.07) Unadjusted Elective admissions (incidence rate ratio)
0.078 0.87 (0.74 to 1.02) Adjusted
0.241 0.90 (0.76 to 1.07) Combined model
0.621 0.96 (0.81 to 1.13) Unadjusted Outpatient attendances (incidence rate ratio)
0.814 1.01 (0.92 to 1.12) Adjusted
0.575 0.95 (0.81 to 1.13) Combined model
0.135 0.85 (0.70 to 1.05) Unadjusted Emergency department visits (incidence rate ratio)
0.044 0.85 (0.73 to 1.00) Adjusted
0.091 0.86 (0.72 to 1.02) Combined model
0.023 −0.64 (−1.14 to −0.10) Unadjusted Bed days (difference in geometric means)
0.047 −0.44 (−0.85 to −0.01) Adjusted
0.013 −0.58 (−1.00 to −0.13) Combined model
0.181 −449 (−964 to 243) Unadjusted Tariff costs (difference in geometric means (£))
0.290 −242 (−629 to 228) Adjusted
0.184 −382 (−840 to 206) Combined model
*One of the models did not converge for mortality.
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Fig 1 CONSORT diagram
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RESEARCHFig 2 Crude trends in secondary care activity for patients recruited into the study
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RESEARCHFig 3 Kaplan-Meier survival analysis for admission proportion
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